↓ Skip to main content

Dove Medical Press

Real-World Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis: Study Protocol for a Prospective Observational Study (ShangHai at Risk for Psychosis-Phase 2)

Overview of attention for article published in Neuropsychiatric Disease and Treatment, December 2019
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
48 Mendeley
Title
Real-World Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis: Study Protocol for a Prospective Observational Study (ShangHai at Risk for Psychosis-Phase 2)
Published in
Neuropsychiatric Disease and Treatment, December 2019
DOI 10.2147/ndt.s230904
Pubmed ID
Authors

GuiSen Wu, RanPiao Gan, ZhiXing Li, LiHua Xu, XiaoChen Tang, YanYan Wei, YeGang Hu, HuiRu Cui, HuiJun Li, YingYing Tang, Li Hui, XiaoHua Liu, ChunBo Li, JiJun Wang, TianHong Zhang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 21%
Student > Ph. D. Student 6 13%
Student > Doctoral Student 4 8%
Student > Bachelor 4 8%
Student > Master 3 6%
Other 5 10%
Unknown 16 33%
Readers by discipline Count As %
Psychology 13 27%
Nursing and Health Professions 6 13%
Medicine and Dentistry 5 10%
Biochemistry, Genetics and Molecular Biology 1 2%
Agricultural and Biological Sciences 1 2%
Other 4 8%
Unknown 18 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 December 2019.
All research outputs
#22,771,990
of 25,387,668 outputs
Outputs from Neuropsychiatric Disease and Treatment
#2,583
of 3,131 outputs
Outputs of similar age
#404,322
of 473,923 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#53
of 88 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,131 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 473,923 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.